Similarly, blockade of ABCB5 with anti-ABCB5 mAb or downregulation with shRNA resulted in decreased proliferation of glioblastoma multiforme and sensitized cells to temozolomide in both cell culture and xenograft models[41]. The gene discussed is ABCB5; the disease is glioblastoma.